1379337-32-2

Basic information

• Product Name: (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester
• Synonyms: (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester
• CAS NO: 1379337-32-2
• Molecular Formula: C8H11N3O3
• Molecular Weight: 197.19124
• EINECS: -0
• Mol File: 1379337-32-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester(1379337-32-2)
• EPA Substance Registry System: (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester(1379337-32-2)

Safety Data

• Hazardous Substances Data: 1379337-32-2(Hazardous Substances Data)

Usage

General Description

(2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester is a chemical compound that belongs to the class of carboxylic acid esters. It is derived from the combination of carbaMic acid and pyrrol-1-yl, which results in the formation of a carbaMoyl-pyrrol-1-yl group. The ethyl ester group is also attached to the carbaMic acid, indicating that it is an ethyl ester derivative. (2-CarbaMoyl-pyrrol-1-yl)-carbaMic acid ethyl ester may have potential applications in pharmaceutical research and drug development, as carboxylic acid esters are commonly used in the synthesis of various pharmaceutical compounds. Additionally, it may also have uses in organic chemistry as a building block for the synthesis of complex organic molecules. Further research and analysis would be needed to fully understand the potential uses and properties of this compound.

Upstream product

• 1003-29-8 2-pyrrole aldehyde 
• 4513-94-4 1H-pyrrole-2-carbonitrile 
• 159326-66-6 N-amino-1H-pyrrole-2-carbonitrile 
• 541-41-3 chloroformic acid ethyl ester 
• 159326-69-9 1-aminopyrrole-2-carboxamide 

Downstream Products

• 918538-04-2 pyrrolo[2,1-f][1,2,4]triazine-2,4(1H, 3H)-dione 
• 1561811-16-2 2-chloro-4-phenylpyrrolo[2,1-f][1,2,4]triazine 
• 1561810-95-4 N-{2-methyl-5-[(morpholinyl)methyl]phenyl}-4-({4-phenylpyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)benzamide 
• 1561810-97-6 N-(2-methyl-5-(4-morpholinyl)methylphenyl)-4-(4-(pyridin-2-yl)pyrrolo[2,1-f][1,2,4]triazin-2-ylamino)benzamide 
• 1561811-00-4 N-(2-methyl-5-(4-morpholinylmethyl)phenyl)-4-(4-(pyridin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-2-ylamino)benzamide 
• 1561811-30-0 5-((4-(4-(trifluoromethoxy)phenyl)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)pyridine-2-carboxylic acid 
• 1561811-36-6 N-[5-(hydroxymethyl)-2-methylphenyl]-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-45-7 N-[5-(chloromethyl)-2-methylphenyl]-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-03-7 N-{2-methyl-5-[(morpholinyl)methyl]phenyl}-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-39-9 N-[3-(hydroxymethyl)phenyl]-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-48-0 N-[3-(chloromethyl)phenyl]-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-06-0 N-{3-[(morpholinyl)methyl]phenyl}-5-({4-[4-(trifluoromethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl}amino)pyridine-2-carboxamide 
• 1561811-42-4 N-(5-(hydroxymethyl)-2-methylphenyl)-5-((4-(pyridin-2-yl)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)pyridine-2-carboxamide 
• 1561811-51-5 N-(5-(chloromethyl)-2-methylphenyl)-5-((4-(pyridin-2-yl)pyrrolo[2,1-f][1,2,4]triazin-2-yl)amino)pyridine-2-carboxamide 

Relevant articles and documents

2 - amino-pyrrolo [1, 2 - f] [1, 2, 4] triazine compounds, synthetic method and application

The invention discloses 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, and a synthesis method and application thereof, particularly 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, or pharmaceutically acceptable salts, hydrate, solvate or prodrug thereof.

Heterocyclic amines Hedgehog signal pathway inhibitor

The invention relates to the field of biological medicine, in particular to a heterocyclic amine compound and an application thereof, namely a general formula (I) compound and acceptable salt in the pharmaceutical field. The compound can be used in the Hedgehog signal transduction inhibitor application and various medical applications (please see the formula in the specification). The invention further relates to a preparation method with the general formula (I).

PYRROLOTRIAZINE KINASE INHIBITORS

The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.